Peer-influenced content. Sources you trust. No registration required. This is HCN.
MDLinx
Silent inactivation (where neutralizing antibodies reduce enzymatic activity without clinical symptoms) can go undetected without therapeutic drug monitoring, leading to subtherapeutic asparagine depletion and increased relapse risk.
Hematology December 1st 2025
Journal of Pharmacy Practice (JPP)
NPP management resulted in similar TTR as UMC. Due to few thromboembolic and hemorrhagic events, more studies are needed to determine the effects of NPP warfarin management on clinical outcomes.
Cardiology September 3rd 2025
Rare Disease Advisor
“Even a single amino acid mismatch between donor and recipient HLA can induce humoral response, influenced not just by sequence differences but also by structural and chemical properties.”
Hematology August 18th 2025
Hematology Advisor
“The enrichment of diverse immune‐related pathways in the HIC cluster suggests that these patients could be prime candidates for future immunotherapy strategies.”
Medical Xpress
“By disabling Ant2, we triggered a complete shift in how T cells produce and use energy. This reprogramming made them significantly better at recognizing and killing cancer cells.”
Epoch Health
“The damage to DNA lasts a lifetime. Probably the biggest concern is the increased risk of other cancers developing as a result of exposure to prior chemotherapy.”